Skip to main content

An Open Label Study of CM-AT for the Treatment of Children With Autism

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about An Open Label Study of CM-AT for the Treatment of Children With Autism

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding

A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

A Study of SIMPONIĀ® to Arrest Beta-cell Loss in Type 1 Diabetes

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of SIMPONIĀ® to Arrest Beta-cell Loss in Type 1 Diabetes

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

Global Anticoagulant Registry in the Field

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Global Anticoagulant Registry in the Field

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • …
  • Next page Next
  • Last page Last
Subscribe to